HIF1A and hepatocellular carcinoma: In multiple studies involving a range of treatment modalities, as well as a meta-analysis, HIF-1α immunohistochemistry of tumor biopsies has revealed increased expression in over 60% of HCC cases and a significant association with decreased disease-free and OS (29–33) as well as increased risk of recurrence after radiation therapy (34) or surgery (35).